Loading...
XSTO
EPISb
Market cap5mUSD
Jul 09, Last price  
0.06SEK
1D
-4.08%
1Q
4.27%
Jan 2017
-99.44%
IPO
-99.87%
Name

Episurf Medical AB

Chart & Performance

D1W1MN
XSTO:EPISb chart
P/E
P/S
3.59
EPS
Div Yield, %
Shrs. gr., 5y
49.02%
Rev. gr., 5y
21.98%
Revenues
14m
+3.85%
000037,916173,0261,016,4622,405,6142,490,2484,000,0004,900,0005,000,0006,500,0006,600,00010,300,00013,000,00013,500,000
Net income
-58m
L-23.42%
-540,241-2,786,253-4,458,653-15,769,779-22,856,694-32,914,421-43,974,662-61,667,464-61,093,452-57,800,000-70,600,000-64,600,000-69,500,000-77,300,000-94,800,000-76,000,000-58,200,000
CFO
-55m
L-22.55%
-1,998,651-3,913,785-15,045,172-20,642,962-31,659,426-38,039,032-56,096,044-61,381,599-52,300,000-59,200,000-54,100,000-59,700,000-69,500,000-84,800,000-71,400,000-55,300,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The company also offers Epioscopy to identify and visualize femoral knee joint cartilage and bone lesions, and tibia, as well as defects on the cruciate ligaments and menisci; Epiguide, a surgical drill guide; and µiFidelity, a web platform for order management, communication, personalized design, and surgical pre-planning. In addition, it is developing Episealer MTP implant, an implant for the MTP joint of the big toe in the foot. Further, the company offers Talus Osteotomy Guide (TOG) that is designed to fit on the patient’s distal tibia using CT and MRI images; MRI protocol to ensure correct damage assessment, 3D visualization, and device design; and Damage Marking Report (DMR) that enables 3D visualization of damage in the joint surface and underlaying bone defects, as well as other findings relevant when selecting the right treatment for the patient. The company was formerly known as Diamorph Medtech AB and changed its name to Episurf Medical AB (publ) in 2010. Episurf Medical AB (publ) was incorporated in 2008 and is based in Stockholm, Sweden.
IPO date
Nov 05, 2010
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT